{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:36:00Z","timestamp":1793853360602,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.semarthrit.2024.152469","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T16:03:49Z","timestamp":1716221029000},"page":"152469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study."],"prefix":"10.1016","volume":"67","author":[{"given":"Sara","family":"Boukhlal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Chouchana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Saadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Dunogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Murarasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Regent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Chaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2024.152469_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"10373","key":"10.1016\/j.semarthrit.2024.152469_bib0002","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152469_bib0003","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152469_bib0004","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.2023.8872","article-title":"Polypharmacy and deprescribing","volume":"330","author":"Vordenberg","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152469_bib0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/acr.24766","article-title":"Polypharmacy and potentially inappropriate medication use in older adults with systemic lupus erythematosus","volume":"75","author":"S\u00e9guin","year":"2023","journal-title":"Arthritis Care Res"},{"issue":"SI3","key":"10.1016\/j.semarthrit.2024.152469_bib0006","doi-asserted-by":"crossref","first-page":"SI237","DOI":"10.1093\/rheumatology\/kead307","article-title":"The prevalence and impact of polypharmacy in rheumatology","volume":"62","author":"Lewis","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2024.152469_bib0007","first-page":"roac155","article-title":"Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: a single-centre, cross-sectional study","author":"Miyake","year":"2022","journal-title":"Mod Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152469_bib0008","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/rheumatology\/kez037","article-title":"Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis","volume":"58","author":"Bechman","year":"2019","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.semarthrit.2024.152469_bib0009","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3899\/jrheum.160818","article-title":"Polypharmacy and unplanned hospitalizations in patients with rheumatoid arthritis","volume":"44","author":"Filkova","year":"2017","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152469_bib0010","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s10067-023-06646-0","article-title":"Prevalence and factors associated with polypharmacy among patients with rheumatoid arthritis: a single-centre, cross-sectional study","volume":"42","author":"Miyake","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2024.152469_bib0011","doi-asserted-by":"crossref","first-page":"adv00600","DOI":"10.2340\/actadv.v101.439","article-title":"Treatment of digital ulcers and reflux oesophagitis in a patient with systemic sclerosis: increased risk of hepatotoxicity due to a potential drug-drug interaction between bosentan and vonoprazan","volume":"101","author":"Kimura","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152469_bib0012","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jbspin.2009.04.010","article-title":"Liver impairment after concomitant administration of bosentan and clarithromycin in systemic sclerosis","volume":"77","author":"Caramaschi","year":"2010","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152469_bib0013","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/RHU.0b013e31819bc71f","article-title":"Severe hepatotoxicity in a patient on bosentan upon addition of methotrexate: reversible with resumption of methotrexate without bosentan","volume":"15","author":"Dwyer","year":"2009","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152469_bib0014","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13318-021-00728-7","article-title":"A drug\u2013drug interaction study to investigate the effect of nintedanib on the pharmacokinetics of microgynon (ethinylestradiol and levonorgestrel) in female patients with systemic sclerosis-associated interstitial lung disease","volume":"47","author":"Vonk","year":"2022","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.semarthrit.2024.152469_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152270","article-title":"Co prescription of anti-acid therapy reduces the bioavailability of mycophenolate mofetil in systemic sclerosis patients: a crossover trial","volume":"63","author":"Alex","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152469_bib0016","doi-asserted-by":"crossref","DOI":"10.1111\/joim.13689","article-title":"Mouth opening in systemic sclerosis: a longitudinal analysis from the French National Cohort Study","author":"Chaigne","year":"2023","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152469_bib0017","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199410020-00001","article-title":"Harmonisation in pharmacovigilance","volume":"10","author":"Edwards","year":"1994","journal-title":"Drug-Safety"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152469_bib0018","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13075-020-2113-6","article-title":"Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis","volume":"22","author":"Ledoult","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2024.152469_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2023.112317","article-title":"Polypharmacy, physical activity, and sedentary time in older adults: a scoping review","volume":"183","author":"de Souza","year":"2023","journal-title":"Exp Gerontol"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152469_bib0020","article-title":"Interventions to improve the appropriate use of polypharmacy for older people","volume":"10","author":"Cole","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152469_bib0021","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cger.2022.05.004","article-title":"Polypharmacy in older adults","volume":"38","author":"Canio","year":"2022","journal-title":"Clin Geriatr Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152469_bib0022","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/msc.112","article-title":"Polypharmacy among people with rheumatoid arthritis: the role of age, disease duration and comorbidity","volume":"5","author":"Treharne","year":"2007","journal-title":"Musculoskeletal Care"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152469_bib0023","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0897190019869158","article-title":"High levels of polypharmacy in rheumatoid arthritis-A challenge not covered by current management recommendations: data from a large real-life study","volume":"34","author":"Gomides","year":"2021","journal-title":"J Pharm Pract"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152469_bib0024","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/rheumatology\/kex469","article-title":"Recurrent serious infections in patients with rheumatoid arthritis-results from the British Society for Rheumatology Biologics Register","volume":"57","author":"Subesinghe","year":"2018","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152469_bib0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/RHU.0000000000000463","article-title":"Disease activity score on 28 joints and polypharmacy are independent predictors for health-related quality of life evaluated by INCAVISA in patients with rheumatoid arthritis","volume":"22","author":"Gonz\u00e1lez-Gamboa","year":"2016","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152469_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002520","article-title":"Medication burden in young adults with juvenile idiopathic arthritis: data from a multicentre observational study","volume":"8","author":"Montag","year":"2022","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152469_bib0027","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1060028016672035","article-title":"Interaction between low-dose methotrexate and nonsteroidal anti-inflammatory drugs, penicillins, and proton pump inhibitors","volume":"51","author":"Hall","year":"2017","journal-title":"Ann Pharmacother"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T02:47:21Z","timestamp":1720061241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224001094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":27,"alternative-id":["S0049017224001094"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152469","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152469"}}